View in EDS

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).

Saved in:
Bibliographic Details
Title: Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Authors: Holch, J.W.1,2 Julian.Holch@med.uni-muenchen.de, Ricard, I.3, Stintzing, S.1,2, Fischer von Weikersthal, L.4, Decker, T.5, Kiani, A.6, Vehling-Kaiser, U.7, Heintges, T.8, Kahl, C.9, Kullmann, F.10, Scheithauer, W.11, Moehler, M.12, Jelas, I.1,2, Modest, D.P.1,2, Westphalen, C.B.1,2, von Einem, J.C.1,2, Michl, M.1,2, Heinemann, V.1,2
Source: European Journal of Cancer. Jan2019, Vol. 106, p115-125. 11p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 133554489
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Holch%2C+J%2EW%2E%22">Holch, J.W.</searchLink><relatesTo>1,2</relatesTo><i> Julian.Holch@med.uni-muenchen.de</i><br /><searchLink fieldCode="AR" term="%22Ricard%2C+I%2E%22">Ricard, I.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Stintzing%2C+S%2E%22">Stintzing, S.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Fischer+von+Weikersthal%2C+L%2E%22">Fischer von Weikersthal, L.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Decker%2C+T%2E%22">Decker, T.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Kiani%2C+A%2E%22">Kiani, A.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Vehling-Kaiser%2C+U%2E%22">Vehling-Kaiser, U.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Heintges%2C+T%2E%22">Heintges, T.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Kahl%2C+C%2E%22">Kahl, C.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Kullmann%2C+F%2E%22">Kullmann, F.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Scheithauer%2C+W%2E%22">Scheithauer, W.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Moehler%2C+M%2E%22">Moehler, M.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Jelas%2C+I%2E%22">Jelas, I.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Modest%2C+D%2EP%2E%22">Modest, D.P.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Westphalen%2C+C%2EB%2E%22">Westphalen, C.B.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22von+Einem%2C+J%2EC%2E%22">von Einem, J.C.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Michl%2C+M%2E%22">Michl, M.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Heinemann%2C+V%2E%22">Heinemann, V.</searchLink><relatesTo>1,2</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Jan2019, Vol. 106, p115-125. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133554489
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2018.10.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 115
    Titles:
      – TitleFull: Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Holch, J.W.
      – PersonEntity:
          Name:
            NameFull: Ricard, I.
      – PersonEntity:
          Name:
            NameFull: Stintzing, S.
      – PersonEntity:
          Name:
            NameFull: Fischer von Weikersthal, L.
      – PersonEntity:
          Name:
            NameFull: Decker, T.
      – PersonEntity:
          Name:
            NameFull: Kiani, A.
      – PersonEntity:
          Name:
            NameFull: Vehling-Kaiser, U.
      – PersonEntity:
          Name:
            NameFull: Heintges, T.
      – PersonEntity:
          Name:
            NameFull: Kahl, C.
      – PersonEntity:
          Name:
            NameFull: Kullmann, F.
      – PersonEntity:
          Name:
            NameFull: Scheithauer, W.
      – PersonEntity:
          Name:
            NameFull: Moehler, M.
      – PersonEntity:
          Name:
            NameFull: Jelas, I.
      – PersonEntity:
          Name:
            NameFull: Modest, D.P.
      – PersonEntity:
          Name:
            NameFull: Westphalen, C.B.
      – PersonEntity:
          Name:
            NameFull: von Einem, J.C.
      – PersonEntity:
          Name:
            NameFull: Michl, M.
      – PersonEntity:
          Name:
            NameFull: Heinemann, V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 09598049
          Numbering:
            – Type: volume
              Value: 106
          Titles:
            – TitleFull: European Journal of Cancer
              Type: main
ResultId 1